Incretin hormones regulate microglia oxidative stress, survival and expression of trophic factors

European Journal of Cell Biology

Volumn 96, Issue 3, 2017, Pages 240-253

  Spielman, Lindsay Joy ^a   Gibson, Deanna Lynn ^a   Klegeris, Andis ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Alzheimer's disease; Apoptosis; Cell death; Incretins; Microglia degeneration; Parkinson's disease

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; COPPER ZINC SUPEROXIDE DISMUTASE; CYCLIC AMP DEPENDENT PROTEIN KINASE; GASTRIC INHIBITORY POLYPEPTIDE; GASTRIC INHIBITORY POLYPEPTIDE RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLUCAGON LIKE PEPTIDE 1; GLUCAGON LIKE PEPTIDE 1 RECEPTOR; GLUTATHIONE PEROXIDASE 1; INCRETIN; NERVE GROWTH FACTOR; NITRIC OXIDE; PHOSPHATIDYLINOSITOL 3 KINASE; REACTIVE OXYGEN METABOLITE; UNCLASSIFIED DRUG; GLUCAGON LIKE PEPTIDE; GLUCAGON LIKE PEPTIDE RECEPTOR; GLUTATHIONE PEROXIDASE; HORMONE RECEPTOR; REACTIVE NITROGEN SPECIES;

ANIMAL CELL; APOPTOSIS; ARTICLE; ASTROCYTE; CELL SURVIVAL; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; MICROGLIA; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR BINDING; UPREGULATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CELL LINE; GENETICS; METABOLISM; MOUSE; TUMOR CELL LINE;

ANIMALS; APOPTOSIS; ASTROCYTES; CELL LINE; CELL LINE, TUMOR; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; GASTRIC INHIBITORY POLYPEPTIDE; GLUCAGON-LIKE PEPTIDE RECEPTORS; GLUCAGON-LIKE PEPTIDES; GLUTATHIONE PEROXIDASE; HUMANS; INCRETINS; MICE; MICE, INBRED C57BL; MICROGLIA; NERVE GROWTH FACTORS; OXIDATIVE STRESS; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN SPECIES; RECEPTORS, GASTROINTESTINAL HORMONE; SUPEROXIDE DISMUTASE-1;

EID: 85015792585     PISSN: 01719335     EISSN: 16181298     Source Type: Journal    
DOI: 10.1016/j.ejcb.2017.03.004     Document Type: Article

References (84)

1. Allen, C.L., Bayraktutan, U., Oxidative stress and its role in the pathogenesis of ischaemic stroke. Int. J. Stroke 4 (2009), 461–470.
2. Baggio, L.L., Drucker, D.J., Biology of incretins: GLP-1 and GIP. Gastroenterology 132 (2007), 2131–2157.
3. Besterman, H.S., Mallinson, C.N., Modigliani, R., Christofides, N.D., Pera, A., Ponti, V., Sarson, D.L., Bloom, S.R., Gut hormones in inflammatory bowel disease. Scand. J. Gastroenterol. 18 (1983), 845–852.
4. Betteridge, D.J., What is oxidative stress?. Metabolism 49 (2000), 3–8.
5. Bifrare, Y.D., Kummer, J., Joss, P., Tauber, M.G., Leib, S.L., Brain-derived neurotrophic factor protects against multiple forms of brain injury in bacterial meningitis. J. Infect. Dis. 191 (2005), 40–45.
6. Botta, A., Laher, I., Beam, J., Decoffe, D., Brown, K., Halder, S., Devlin, A., Gibson, D.L., Ghosh, S., Short term exercise induces PGC-1alpha, ameliorates inflammation and increases mitochondrial membrane proteins but fails to increase respiratory enzymes in aging diabetic hearts. PLoS One, 8, 2013, e70248.
7. Budni, J., Bellettini-Santos, T., Mina, F., Garcez, M.L., Zugno, A.I., The involvement of BDNF, NGF and GDNF in aging and Alzheimer's disease. Aging Dis. 6 (2015), 331–341.
8. Buhren, B.A., Gasis, M., Thorens, B., Muller, H.W., Bosse, F., Glucose-dependent insulinotropic polypeptide (GIP) and its receptor (GIPR): cellular localization, lesion-affected expression, and impaired regenerative axonal growth. J. Neurosci. Res. 87 (2009), 1858–1870.
9. Buldak, L., Labuzek, K., Buldak, R.J., Machnik, G., Boldys, A., Okopien, B., Exenatide (a GLP-1 agonist) improves the antioxidative potential of in vitro cultured human monocytes/macrophages. Naunyn. Schmiedebergs Arch. Pharmacol. 388 (2015), 905–919.
10. Caini, S., Bagnoli, S., Palli, D., Saieva, C., Ceroti, M., Bendinelli, B., Assedi, M., Masala, G., Total and cancer mortality in a cohort of ulcerative colitis and Crohn's disease patients: the Florence inflammatory bowel disease study, 1978–2010. Dig. Liver Dis. 48 (2016), 1162–1167.
11. Cao, B., Bauer, I.E., Sharma, A.N., Mwangi, B., Frazier, T., Lavagnino, L., Zunta-Soares, G.B., Walss-Bass, C., Glahn, D.C., Kapczinski, F., Nielsen, D.A., Soares, J.C., Reduced hippocampus volume and memory performance in bipolar disorder patients carrying the BDNF val66met met allele. J. Affect. Disord. 198 (2016), 198–205.
12. Cao, L., Li, D., Feng, P., Li, L., Xue, G.F., Li, G., Holscher, C., A novel dual GLP-1 and GIP incretin receptor agonist is neuroprotective in a mouse model of Parkinson's disease by reducing chronic inflammation in the brain. Neuroreport 27 (2016), 384–391.
13. Chen, Z., Zhong, C., Oxidative stress in Alzheimer's disease. Neurosci. Bull. 30 (2014), 271–281.
14. Ding, A.H., Nathan, C.F., Stuehr, D.J., Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J. Immunol. 141 (1988), 2407–2412.
15. Dozier, K.C., Cureton, E.L., Kwan, R.O., Curran, B., Sadjadi, J., Victorino, G.P., Glucagon-like peptide-1 protects mesenteric endothelium from injury during inflammation. Peptides 30 (2009), 1735–1741.
16. Duarte, E.P., Curcio, M., Canzoniero, L.M., Duarte, C.B., Neuroprotection by GDNF in the ischemic brain. Growth Factors 30 (2012), 242–257.
17. El Kossi, M.M., Zakhary, M.M., Oxidative stress in the context of acute cerebrovascular stroke. Stroke 31 (2000), 1889–1892.
18. Essers, J.B., Lee, J.J., Kugathasan, S., Stevens, C.R., Grand, R.J., Daly, M.J., Consortium, N.I.G., Established genetic risk factors do not distinguish early and later onset Crohn's disease. Inflamm. Bowel Dis. 15 (2009), 1508–1514.
19. Farrand, A.Q., Gregory, R.A., Scofield, M.D., Helke, K.L., Boger, H.A., Effects of aging on glutamate neurotransmission in the substantia nigra of GDNF heterozygous mice. Neurobiol. Aging 36 (2015), 1569–1576.
20. Femminella, G.D., Edison, P., Evaluation of neuroprotective effect of glucagon-like peptide 1 analogs using neuroimaging. Alzheimers Dement. 10 (2014), S55–61.
21. Figueiredo, C.P., Pamplona, F.A., Mazzuco, T.L., Aguiar, A.S. Jr., Walz, R., Prediger, R.D., Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases. Behav. Pharmacol. 21 (2010), 394–408.
22. Gault, V.A., O'Harte, F.P., Harriott, P., Mooney, M.H., Green, B.D., Flatt, P.R., Effects of the novel (Pro3)GIP antagonist and exendin(9–39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin. Diabetologia 46 (2003), 222–230.
23. Gejl, M., Gjedde, A., Egefjord, L., Moller, A., Hansen, S.B., Vang, K., Rodell, A., Braendgaard, H., Gottrup, H., Schacht, A., Moller, N., Brock, B., Rungby, J., In Alzheimer's disease, 6-Month treatment with GLP-1 analog prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial. Front. Aging Neurosci., 8, 2016, 108.
24. Gengler, S., McClean, P.L., McCurtin, R., Gault, V.A., Holscher, C., Val(8)GLP-1 rescues synaptic plasticity and reduces dense core plaques in APP/PS1 mice. Neurobiol. Aging 33 (2012), 265–276.
25. Guo, X.J., Tian, X.S., Ruan, Z., Chen, Y.T., Wu, L., Gong, Q., Wang, W., Zhang, H.Y., Dysregulation of neurotrophic and inflammatory systems accompanied by decreased CREB signaling in ischemic rat retina. Exp. Eye Res. 125 (2014), 156–163.
26. Hamilton, A., Patterson, S., Porter, D., Gault, V.A., Holscher, C., Novel GLP-1 mimetics developed to treat type 2 diabetes promote progenitor cell proliferation in the brain. J. Neurosci. Res. 89 (2011), 481–489.
27. Hansen, M.B., Nielsen, S.E., Berg, K., Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J. Immunol. Methods 119 (1989), 203–210.
28. He, B.P., Wen, W., Strong, M.J., Activated microglia (BV-2) facilitation of TNF-alpha-mediated motor neuron death in vitro. J. Neuroimmunol. 128 (2002), 31–38.
29. Iwai, T., Ito, S., Tanimitsu, K., Udagawa, S., Oka, J., Glucagon-like peptide-1 inhibits LPS-induced IL-1beta production in cultured rat astrocytes. Neurosci. Res. 55 (2006), 352–360.
30. Kappe, C., Tracy, L.M., Patrone, C., Iverfeldt, K., Sjoholm, A., GLP-1 secretion by microglial cells and decreased CNS expression in obesity. J. Neuroinflammation, 9, 2012, 276.
31. Kastin, A.J., Akerstrom, V., Pan, W., Interactions of glucagon-like peptide-1 (GLP-1) with the blood-brain barrier. J. Mol. Neurosci. 18 (2002), 7–14.
32. Kim, S.J., Nian, C., Widenmaier, S., McIntosh, C.H., Glucose-dependent insulinotropic polypeptide-mediated up-regulation of beta-cell antiapoptotic Bcl-2 gene expression is coordinated by cyclic AMP (cAMP) response element binding protein (CREB) and cAMP-responsive CREB coactivator 2. Mol. Cell Biol. 28 (2008), 1644–1656.
33. Kim, S.J., Nian, C., McIntosh, C.H., GIP increases human adipocyte LPL expression through CREB and TORC2-mediated trans-activation of the LPL gene. J. Lipid Res. 51 (2010), 3145–3157.
34. Klegeris, A., McGeer, P.L., Interaction of various intracellular signaling mechanisms involved in mononuclear phagocyte toxicity toward neuronal cells. J. Leukoc. Biol. 67 (2000), 127–133.
35. Klegeris, A., McGeer, P.L., Toxicity of human monocytic THP-1 cells and microglia toward SH-SY5Y neuroblastoma cells is reduced by inhibitors of 5-lipoxygenase and its activating protein FLAP. J. Leukoc. Biol. 73 (2003), 369–378.
36. Klegeris, A., Bissonnette, C.J., McGeer, P.L., Modulation of human microglia and THP-1 cell toxicity by cytokines endogenous to the nervous system. Neurobiol. Aging 26 (2005), 673–682.
37. Korsching, S., Auburger, G., Heumann, R., Scott, J., Thoenen, H., Levels of nerve growth factor and its mRNA in the central nervous system of the rat correlate with cholinergic innervation. EMBO J. 4 (1985), 1389–1393.
38. Kurzawa, L., Pellerano, M., Coppolani, J.B., Morris, M.C., Fluorescent peptide biosensor for probing the relative abundance of cyclin-dependent kinases in living cells. PLoS One, 6, 2011, e26555.
39. Lee, J.K., Tansey, M.G., Microglia isolation from adult mouse brain. Methods Mol. Biol. 1041 (2013), 17–23.
40. Lee, Y.S., Park, M.S., Choung, J.S., Kim, S.S., Oh, H.H., Choi, C.S., Ha, S.Y., Kang, Y., Kim, Y., Jun, H.S., Glucagon-like peptide-1 inhibits adipose tissue macrophage infiltration and inflammation in an obese mouse model of diabetes. Diabetologia 55 (2012), 2456–2468.
41. Li, Y., Perry, T., Kindy, M.S., Harvey, B.K., Tweedie, D., Holloway, H.W., Powers, K., Shen, H., Egan, J.M., Sambamurti, K., Brossi, A., Lahiri, D.K., Mattson, M.P., Hoffer, B.J., Wang, Y., Greig, N.H., GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc. Natl. Acad. Sci. U. S. A. 106 (2009), 1285–1290.
42. Liu, B., Wang, K., Gao, H.M., Mandavilli, B., Wang, J.Y., Hong, J.S., Molecular consequences of activated microglia in the brain: overactivation induces apoptosis. J. Neurochem. 77 (2001), 182–189.
43. Madeira, J.M., Renschler, C.J., Mueller, B., Hashioka, S., Gibson, D.L., Klegeris, A., Novel protective properties of auranofin: inhibition of human astrocyte cytotoxic secretions and direct neuroprotection. Life Sci. 92 (2013), 1072–1080.
44. Maino, B., Ciotti, M.T., Calissano, P., Cavallaro, S., Transcriptional analysis of apoptotic cerebellar granule neurons following rescue by gastric inhibitory polypeptide. Int. J. Mol. Sci. 15 (2014), 5596–5622.
45. Mandrekar-Colucci, S., Landreth, G.E., Microglia and inflammation in Alzheimer's disease. CNS Neurol. Disord. Drug Targets 9 (2010), 156–167.
46. McCloy, R.A., Rogers, S., Caldon, C.E., Lorca, T., Castro, A., Burgess, A., Partial inhibition of Cdk1 in G 2 phase overrides the SAC and decouples mitotic events. ABBV Cell Cycle 13 (2014), 1400–1412.
47. Mosmann, T., Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983), 55–63.
48. Namioka, N., Hanyu, H., Hirose, D., Hatanaka, H., Sato, T., Shimizu, S., Oxidative stress and inflammation are associated with physical frailty in patients with Alzheimer's disease. Geriatr. Gerontol. Int., 2016, 10.1111/ggi.12804.
49. Nosheny, R.L., Mocchetti, I., Bachis, A., Brain-derived neurotrophic factor as a prototype neuroprotective factor against HIV-1-associated neuronal degeneration. Neurotox. Res. 8 (2005), 187–198.
50. Nyberg, J., Anderson, M.F., Meister, B., Alborn, A.M., Strom, A.K., Brederlau, A., Illerskog, A.C., Nilsson, O., Kieffer, T.J., Hietala, M.A., Ricksten, A., Eriksson, P.S., Glucose-dependent insulinotropic polypeptide is expressed in adult hippocampus and induces progenitor cell proliferation. J. Neurosci. 25 (2005), 1816–1825.
51. Nyberg, J., Jacobsson, C., Anderson, M.F., Eriksson, P.S., Immunohistochemical distribution of glucose-dependent insulinotropic polypeptide in the adult rat brain. J. Neurosci. Res. 85 (2007), 2099–2119.
52. Oeseburg, H., de Boer, R.A., Buikema, H., van der Harst, P., van Gilst, W.H., Sillje, H.H., Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. Arterioscler. Thromb. Vasc. Biol. 30 (2010), 1407–1414.
53. Ojima, A., Matsui, T., Maeda, S., Takeuchi, M., Yamagishi, S., Glucose-dependent insulinotropic polypeptide (GIP) inhibits signaling pathways of advanced glycation end products (AGEs) in endothelial cells via its antioxidative properties. Horm. Metab. Res. 44 (2012), 501–505.
54. Ouchi, Y., Yagi, S., Yokokura, M., Sakamoto, M., Neuroinflammation in the living brain of Parkinson's disease. Parkinsonism Relat. Disord. 15:Suppl 3 (2009), S200–204.
55. Peng, S., Wuu, J., Mufson, E.J., Fahnestock, M., Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. J. Neurochem. 93 (2005), 1412–1421.
56. Petzold, A., Psotta, L., Brigadski, T., Endres, T., Lessmann, V., Chronic BDNF deficiency leads to an age-dependent impairment in spatial learning. Neurobiol. Learn. Mem. 120 (2015), 52–60.
57. Powis, G., Bonjouklian, R., Berggren, M.M., Gallegos, A., Abraham, R., Ashendel, C., Zalkow, L., Matter, W.F., Dodge, J., Grindey, G., Vlahos, C.J., Wortmannin, a potent and selective inhibitor of phosphatidylinositol-3-kinase. Cancer Res. 54 (1994), 2419–2423.
58. Raedler, T.J., Inflammatory mechanisms in major depressive disorder. Curr. Opin. Psychiatry 24 (2011), 519–525.
59. Rao, J.S., Kim, H.W., Harry, G.J., Rapoport, S.I., Reese, E.A., Increased neuroinflammatory and arachidonic acid cascade markers and reduced synaptic proteins, in the postmortem frontal cortex from schizophrenia patients. Schizophr. Res. 147 (2013), 24–31.
60. Rogers, J., Mastroeni, D., Leonard, B., Joyce, J., Grover, A., Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder?. Int. Rev. Neurobiol. 82 (2007), 235–246.
61. Rohnert, P., Schmidt, W., Emmerlich, P., Goihl, A., Wrenger, S., Bank, U., Nordhoff, K., Tager, M., Ansorge, S., Reinhold, D., Striggow, F., Dipeptidyl peptidase IV, aminopeptidase N and DPIV/APN-like proteases in cerebral ischemia. J. Neuroinflammation, 9, 2012, 44.
62. Salmina, A.B., Neuron-glia interactions as therapeutic targets in neurodegeneration. J. Alzheimers Dis. 16 (2009), 485–502.
63. Scheff, S.W., Ansari, M.A., Mufson, E.J., Oxidative stress and hippocampal synaptic protein levels in elderly cognitively intact individuals with Alzheimer's disease pathology. Neurobiol. Aging 42 (2016), 1–12.
64. Seino, Y., Fukushima, M., Yabe, D., GIP and GLP-1, the two incretin hormones: similarities and differences. J. Diabetes Investig. 1 (2010), 8–23.
65. Sharma, M.K., Jalewa, J., Holscher, C., Neuroprotective and anti-apoptotic effects of liraglutide on SH-SY5Y cells exposed to methylglyoxal stress. J. Neurochem. 128 (2014), 459–471.
66. Shin, S., Le Lay, J., Everett, L.J., Gupta, R., Rafiq, K., Kaestner, K.H., CREB mediates the insulinotropic and anti-apoptotic effects of GLP-1 signaling in adult mouse beta-cells. Mol. Metab. 3 (2014), 803–812.
67. Siegel, G.J., Chauhan, N.B., Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Brain Res. Rev. 33 (2000), 199–227.
68. Spielman, L.J., Klegeris, A., The role of insulin and incretins in neuroinflammation and neurodegeneration. Immunoendocrinology 1 (2014), 1–8.
69. Spielman, L.J., Little, J.P., Klegeris, A., Inflammation and insulin/IGF-1 resistance as the possible link between obesity and neurodegeneration. J. Neuroimmunol. 273 (2014), 8–21.
70. Spielman, L.J., Bahniwal, M., Little, J.P., Walker, D.G., Klegeris, A., Insulin modulates In vitro secretion of cytokines and cytotoxins by human glial cells. Curr. Alzheimer. Res. 12 (2015), 684–693.
71. Spielman, L.J., Little, J.P., Klegeris, A., Physical activity and exercise attenuate neuroinflammation in neurological diseases. Brain Res. Bull. 125 (2016), 19–29.
72. Sun, N., Yang, C.X., Liu, Z.F., Li, X.R., Xu, Y., Zhang, K.R., Effects of polymorphisms of serotonin transporter promoter (5-HTTLPR) and brain derived neurotrophic factor gene (G196A rs6265) on the risk of major depressive disorder in the Chinese Han population. Eur. Rev. Med. Pharmacol. Sci. 20 (2016), 1852–1859.
73. Teramoto, S., Miyamoto, N., Yatomi, K., Tanaka, Y., Oishi, H., Arai, H., Hattori, N., Urabe, T., Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia. J.Cereb. Blood Flow Metab. 31 (2011), 1696–1705.
74. Tian, J.Q., Wang, Y., Lin, N., Guo, Y.J., Sun, S.H., Zou, D.J., Active immunization with glucose-dependent insulinotropic polypeptide vaccine influences brain function and behaviour in rats. Scand. J. Immunol. 72 (2010), 1–7.
75. Timper, K., Grisouard, J., Sauter, N.S., Herzog-Radimerski, T., Dembinski, K., Peterli, R., Frey, D.M., Zulewski, H., Keller, U., Muller, B., Christ-Crain, M., Glucose-dependent insulinotropic polypeptide induces cytokine expression, lipolysis, and insulin resistance in human adipocytes. Am. J. Physiol. Endocrinol. Metab. 304 (2013), E1–E13.
76. Trumper, A., Trumper, K., Horsch, D., Mechanisms of mitogenic and anti-apoptotic signaling by glucose-dependent insulinotropic polypeptide in beta(INS-1)-cells. J. Endocrinol. 174 (2002), 233–246.
77. Wang, X., Chen, S., Ma, G., Ye, M., Lu, G., Involvement of proinflammatory factors, apoptosis, caspase-3 activation and Ca2+ disturbance in microglia activation-mediated dopaminergic cell degeneration. Mech. Ageing Dev. 126 (2005), 1241–1254.
78. Wang, C., Xie, N., Zhang, H., Li, Y., Wang, Y., Puerarin protects against beta-amyloid-induced microglia apoptosis via a PI3K-dependent signaling pathway. Neurochem. Res. 39 (2014), 2189–2196.
79. Wu, D., Yotnda, P., Production and detection of reactive oxygen species (ROS) in cancers. J. Vis. Exp., 57, 2011, 3357.
80. Xu, G., Kaneto, H., Laybutt, D.R., Duvivier-Kali, V.F., Trivedi, N., Suzuma, K., King, G.L., Weir, G.C., Bonner-Weir, S., Downregulation of GLP-1 and GIP receptor expression by hyperglycemia: possible contribution to impaired incretin effects in diabetes. Diabetes 56 (2007), 1551–1558.
81. Yang, F., Sun, X., Beech, W., Teter, B., Wu, S., Sigel, J., Vinters, H.V., Frautschy, S.A., Cole, G.M., Antibody to caspase-cleaved actin detects apoptosis in differentiated neuroblastoma and plaque-associated neurons and microglia in Alzheimer's disease. Am. J. Pathol. 152 (1998), 379–389.
82. Yu, Y.W., Hsieh, T.H., Chen, K.Y., Wu, J.C., Hoffer, B., Greig, N.H., Li, Y., Lai, J.H., Chang, C.F., Lin, J.W., Chen, Y.H., Yang, L.Y., Chiang, Y.H., Glucose-dependent insulinotropic polypeptide ameliorates mild traumatic brain injury-induced cognitive and sensorimotor deficits and neuroinflammation in rats. J. Neurotrauma 33 (2016), 2044–2054.
83. Zhang, Y., Chen, Y., Li, L., Holscher, C., Neuroprotective effects of (Val8)GLP-1-Glu-PAL in the MPTP Parkinson's disease mouse model. Behav. Brain Res. 293 (2015), 107–113.
84. Zietek, T., Rath, E., Inflammation meets metabolic disease: gut feeling mediated by GLP-1. Front. Immunol., 7, 2016, 154.